CA Patent

CA2687118A1 — Methods of using low-dose doxepin for the improvement of sleep

Assigned to Currax Pharmaceuticals LLC · Expires 2007-12-13 · 18y expired

What this patent protects

Methods of preventing early awakenings, and improving sleep efficiency in hours (7) and (8) of a period of sleep, by administration of low doses of doxepin (e.g., 1-6 mg).

USPTO Abstract

Methods of preventing early awakenings, and improving sleep efficiency in hours (7) and (8) of a period of sleep, by administration of low doses of doxepin (e.g., 1-6 mg).

Drugs covered by this patent

doxepin-hydrochloride (DOXEPIN HYDROCHLORIDE)

Patent Metadata

Patent number: CA2687118A1
Jurisdiction: CA
Classification: —
Expires: 2007-12-13
Drug substance claim: No
Drug product claim: No
Assignee: Currax Pharmaceuticals LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.